top of page

Key Considerations for Selecting the Right CRO for Your Clinical Trial

  • maninon0
  • Sep 30
  • 1 min read
The cost of delay can be more than 800K.

80% of clinical trials miss enrollment targets, and each day of delay costs $800K in lost sales.

 

Choosing a CRO isn’t just procurement. It’s a strategic decision.

 

Rubix LS builds partnerships based on transparency and trust, giving sponsors real-time insights, aligned incentives, and faster, more reliable trial outcomes.

 

Turn your CRO from a cost center into a strategic advantage. Make it the right CRO.

 

Read the full white paper here:



image.png
  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • Whatsapp

Rubix LS: We’re the Health Outcomes Architect Company, designing a healthier future for every community.

image.png

Join our mailing list

image.png
image.png

Designing health outcomes for the end in mind
is best for patients & the industries that serve them.

Our mission is to design health outcomes that serve every community by addressing the full range of factors that drive health from biological to environmental to socioeconomic. We are pioneers of holistic, precision-focused approaches that go beyond traditional medicine and looks at deeper systemic factors affecting health and design for that that benefits both patients, the healthcare system, and the industries that support all of it.

Copyright © 2025 Rubix Life Sciences | Privacy Policy

bottom of page